ExpreS2ion Biotech Holding AB Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
ExpreS2ion Biotech Holding AB cash flow reinvestment rate. ExpreS2ion Biotech Holding AB (EXPRS2) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr684.00K. Explore EXPRS2 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr684.00K
SEK
Capital Expenditures
Skr0.00
SEK
ExpreS2ion Biotech Holding AB Cash Flow Reinvestment Rate by Year (None–None)
ExpreS2ion Biotech Holding AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for ExpreS2ion Biotech Holding AB. For the full cash flow conversion analysis, see EXPRS2 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow